<DOC>
	<DOCNO>NCT02540187</DOCNO>
	<brief_summary>Haemophilia rare serious congenital defect blood coagulation due genetic mutation sexual chromosome . It affect quasi-essentially men responsible bleeding . There two type haemophilia : Haemophilia A , ( 85 % case ) , due factor VIII ( FVIII ) deficiency Haemophilia B ( 15 % case ) due factor IX ( FIX ) deficiency . According intensity defect , three form haemophilia : severe ( FVIII FIX low 1 % ) , moderate ( factor level 1 5 % ) , minor ( factor level 5 40 % ) . For level factor VIII IX , hemorrhagic manifestation variable one patient . Moreover , several study show haemophilic B patient bleed less consume few anti-hemophilic concentrate haemophilic A patient . The main inhibitor coagulation antithrombin , Protein C-Protein S-Thrombomodulin system , tissue factor pathway inhibitor ( TFPI ) . TFPI specific exclusive inhibitor tissue factor pathway main way plasmatic coagulation start . TFPI potent direct inhibitor factor Xa Xa-dependent inhibitor VIIa-Tissue Factor ( TF ) complex . In hemophilic patient , production Xa amplification pathway strongly altered factor VIII IX deficiency , thrombin generation ( via Xa ) come exclusively TFPI regulate tissue factor pathway . We thus say haemophilic patient bleed , also presence TFPI inhibit time Xa complex TF-VIIa soon factor Xa generate .</brief_summary>
	<brief_title>Tissue Factor Pathway Inhibitor ( TFPI ) Haemorrhagic Manifestations Haemophilia A B Patients</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Thromboplastin</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<mesh_term>Lipoprotein-associated coagulation inhibitor</mesh_term>
	<criteria>Haemophilia A B patient 18 65 year old , whatever severity disease , sign informed consent form Ondemand prophylactic therapy . Regular monitoring investigator center . Haemophilia patient 18 . Presence inhibitor time study period . Patients receive factor VIII concentrate le 72 hour factor IX concentrate le 96 hour blood collection Patients refuse sign inform consent Patient data last 5 year least available . No regular monitoring haemophilia center ( require least one visit every 18 month severe moderate hemophiliac patient ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>haemophilia</keyword>
	<keyword>TFPI</keyword>
	<keyword>thrombin generation</keyword>
	<keyword>hemorrhagic score</keyword>
</DOC>